학술논문
Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients—authors' reply
Document Type
Letter
Author
Source
In: Alimentary Pharmacology and Therapeutics . (Alimentary Pharmacology and Therapeutics, March 2023, 57(6):743-744)
Subject
Language
English
ISSN
13652036
02692813
02692813